“Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice” (2008) Farmeconomia. Health Economics and Therapeutic Pathways, 9(4), pp. 173–181. doi:10.7175/fe.v9i4.235.